|
How many volunteers were present at the Congress? : |
Around 3000 |
|
Delegates from which countries presented in the congress? : |
Most of the countries all over the world including Spain, Italy, Netherlands, UK, Germany, USA, New Zealand, Japan, South Africa, Sweden, Canada, China, Iran, ... |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
WSPID |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
There were some questions about the details of our protocols and the role of cannabinoid receptors in RSV pathogenesis. Taken together the results of our study attract many attentions and science exchange. |
|
If you met staff members, please list their full names & positions. : |
Dr. Asuncion Maria Mejias, USA
Dr. Louis Bont, Netherlands
Dr. Federico Martinon-Torres, Spain
Dr. Octavio Ramilo, USA |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
There were several "Meet the Professor" Sessions offered in the morning. Meet the Professor Sessions provide participants with the opportunity to be updated about the topic of interest in a highly interactive manner. It will be valuable if we can manage this kind of activities in our national congress as well. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Visa, Money transfer as usual! |
|
Please give a briefing of your own observations and outcomes of the congress: : |
ESPID 2017 have prepared an exciting programme with hot topics covering the entire field of paediatric infection-related diseases, and involving a large number of internationally renowned experts. The networking with experts’ from different backgrounds encourages new research ideas and facilitates the development of future multicentre projects. Therefore, ESPID provided this space to networking for both already established research networks as well as research newcomers to present their future projects. There were interesting plenary sessions in Dengue & Zika epidemics, evolutionary biology & microbiology, HIV cure for children and the latest in vaccine research & implementation. These sessions complemented by an exceptional schedule of symposia sessions in Group A Strep, Tuberculosis, congenital infections, infections in the oncology child, antimicrobial stewardship, vaccines, diagnosis through host response and many more... I have also extended my knowledge of the latest scientific developments in the pediatric fields. I talked with some main lecturers in different sessions and achieved some opportunities to update my knowledge in different field of viral pediatric infections. |